Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: breast cancer
Age: Between 45 - 74 Years
Women of childbearing potential must not be known to be pregnant or lactating
Patients must be scheduled for, or have intent to schedule, a screening mammogram
Patients must be able to tolerate digital breast tomosynthesis and full-field digital mammographic imaging required by protocol, to be performed at an American College of Radiology Imaging Network (ACRIN)-qualified facility
Patients must be willing and able to provide a written informed consent
Patients must not have symptoms or signs of benign or malignant breast disease (eg, nipple discharge, breast lump) warranting a diagnostic rather than a screening mammogram, and/or other imaging studies (eg, sonogram); patients with breast pain are eligible as long as other criteria are met
Patients must not have had a screening mammogram within the last 11 months prior to date of randomization
Patients must not have previous personal history of breast cancer including ductal carcinoma in situ
Patients must not have breast enhancements (e.g., implants or injections)
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required